|
Published by: Datamonitor
Published: Aug. 28, 2001 - 91 Pages
Table of Contents
DATAMONITOR HEALTHCARE
CONTACT DETAILS
Global Director of
EXECUTIVE SUMMARY
Scope
Key metrics
TABLE OF CONTENTS
EPIDEMIOLOGY
Definition
Symptoms
Diagnostic criteria
Comorbidities
Major depression
Anxiety disorders
Patient potential
Prevalence
Gender breakdown
Epidemiological conclusion
CLINICAL PRACTICE
Introduction
Diagnosis
Guidelines in existense
Diagnosis rate
Treatment
Breakdown of PTSD in anxiety disorders
First line PTSD treatment
Overall PTSD treatment
Influence on PTSD marketing
The individuality of PTSD within the anxiety spectrum
PTSD has a definitive clinical basis
PTSD is therapy resistant
CURRENT PTSD MARKET
Antidepressant use in PTSD
Zoloft
Paxil
Serzone
Prozac
Luvox
Cipramil/Celexa
Effexor
Remeron
Wellbutrin
Conclusion
Anxiolytic use in PTSD
BuSpar
Benzodiazepines
Other marketed drugs used in PTSD
Risperdal
Depakote
Lamictal
The global PTSD market 2001
THE FUTURE DECODED
Unmet needs in treating PTSD
The PTSD R&D pipeline
Paroxetine
Fluoxetine
The PTSD market 2001-2008
Factors influencing the future PTSD market
Future drug launches
PTSD market forecasts to 2008
PTSD market forecast 2005
PTSD market forecast 2008
APPENDIX
Datamonitor's Central Nervous System Business Unit
Table of tables
Epidemiology
Clinical trials
Websites
R&D research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification and quality control
Physician research questionnaire
Diagnosis
Treatment
Unmet needs
Pricing data
Introduction
Source prices
Ex-manufacturer, wholesaler and retail prices
Data validation and margin calculation
Quality control
Patent expiries
AbstractDatamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder. Anxiety Disorders covered: Eating Disorders (Anorexia Nervosa and Bulimia Nervosa) Generalized Anxiety DisorderObsessive Compulsive Disorder Panic Disorder
Phobias (Specific Phobia and Agoraphobia) Post Traumatic Stress DisorderPremenstrual Dysphoric Disorder Social Anxiety Disorder
Get Full Details About This Report >>
|
